Copyright Reports & Markets. All rights reserved.

Global HIV/AIDS Diagnostics Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 HIV/AIDS Diagnostics Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global HIV/AIDS Diagnostics Market Size Growth Rate by Product
      • 1.4.2 Kits and Reagents
      • 1.4.3 Instruments
      • 1.4.4 Others
    • 1.5 Market by End User
      • 1.5.1 Global HIV/AIDS Diagnostics Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Private Diagnostic Laboratories
      • 1.5.4 Academic and Research Institutes
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global HIV/AIDS Diagnostics Market Size
      • 2.1.1 Global HIV/AIDS Diagnostics Revenue 2014-2025
      • 2.1.2 Global HIV/AIDS Diagnostics Sales 2014-2025
    • 2.2 HIV/AIDS Diagnostics Growth Rate by Regions
      • 2.2.1 Global HIV/AIDS Diagnostics Sales by Regions
      • 2.2.2 Global HIV/AIDS Diagnostics Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 HIV/AIDS Diagnostics Sales by Manufacturers
      • 3.1.1 HIV/AIDS Diagnostics Sales by Manufacturers
      • 3.1.2 HIV/AIDS Diagnostics Sales Market Share by Manufacturers
      • 3.1.3 Global HIV/AIDS Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2 HIV/AIDS Diagnostics Revenue by Manufacturers
      • 3.2.1 HIV/AIDS Diagnostics Revenue by Manufacturers (2014-2019)
      • 3.2.2 HIV/AIDS Diagnostics Revenue Share by Manufacturers (2014-2019)
    • 3.3 HIV/AIDS Diagnostics Price by Manufacturers
    • 3.4 HIV/AIDS Diagnostics Manufacturing Base Distribution, Product Types
      • 3.4.1 HIV/AIDS Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers HIV/AIDS Diagnostics Product Type
      • 3.4.3 Date of International Manufacturers Enter into HIV/AIDS Diagnostics Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global HIV/AIDS Diagnostics Sales by Product
    • 4.2 Global HIV/AIDS Diagnostics Revenue by Product
    • 4.3 HIV/AIDS Diagnostics Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global HIV/AIDS Diagnostics Breakdown Data by End User

    6 North America

    • 6.1 North America HIV/AIDS Diagnostics by Countries
      • 6.1.1 North America HIV/AIDS Diagnostics Sales by Countries
      • 6.1.2 North America HIV/AIDS Diagnostics Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America HIV/AIDS Diagnostics by Product
    • 6.3 North America HIV/AIDS Diagnostics by End User

    7 Europe

    • 7.1 Europe HIV/AIDS Diagnostics by Countries
      • 7.1.1 Europe HIV/AIDS Diagnostics Sales by Countries
      • 7.1.2 Europe HIV/AIDS Diagnostics Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe HIV/AIDS Diagnostics by Product
    • 7.3 Europe HIV/AIDS Diagnostics by End User

    8 Asia Pacific

    • 8.1 Asia Pacific HIV/AIDS Diagnostics by Countries
      • 8.1.1 Asia Pacific HIV/AIDS Diagnostics Sales by Countries
      • 8.1.2 Asia Pacific HIV/AIDS Diagnostics Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific HIV/AIDS Diagnostics by Product
    • 8.3 Asia Pacific HIV/AIDS Diagnostics by End User

    9 Central & South America

    • 9.1 Central & South America HIV/AIDS Diagnostics by Countries
      • 9.1.1 Central & South America HIV/AIDS Diagnostics Sales by Countries
      • 9.1.2 Central & South America HIV/AIDS Diagnostics Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America HIV/AIDS Diagnostics by Product
    • 9.3 Central & South America HIV/AIDS Diagnostics by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa HIV/AIDS Diagnostics by Countries
      • 10.1.1 Middle East and Africa HIV/AIDS Diagnostics Sales by Countries
      • 10.1.2 Middle East and Africa HIV/AIDS Diagnostics Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa HIV/AIDS Diagnostics by Product
    • 10.3 Middle East and Africa HIV/AIDS Diagnostics by End User

    11 Company Profiles

    • 11.1 Siemens Healthineers
      • 11.1.1 Siemens Healthineers Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Siemens Healthineers HIV/AIDS Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Siemens Healthineers HIV/AIDS Diagnostics Products Offered
      • 11.1.5 Siemens Healthineers Recent Development
    • 11.2 Bio-Rad
      • 11.2.1 Bio-Rad Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Bio-Rad HIV/AIDS Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Bio-Rad HIV/AIDS Diagnostics Products Offered
      • 11.2.5 Bio-Rad Recent Development
    • 11.3 Abbott Laboratories
      • 11.3.1 Abbott Laboratories Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Abbott Laboratories HIV/AIDS Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Abbott Laboratories HIV/AIDS Diagnostics Products Offered
      • 11.3.5 Abbott Laboratories Recent Development
    • 11.4 OraSure Technologies
      • 11.4.1 OraSure Technologies Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 OraSure Technologies HIV/AIDS Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 OraSure Technologies HIV/AIDS Diagnostics Products Offered
      • 11.4.5 OraSure Technologies Recent Development
    • 11.5 F. Hoffmann-La Roche
      • 11.5.1 F. Hoffmann-La Roche Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 F. Hoffmann-La Roche HIV/AIDS Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 F. Hoffmann-La Roche HIV/AIDS Diagnostics Products Offered
      • 11.5.5 F. Hoffmann-La Roche Recent Development
    • 11.6 Hologic
      • 11.6.1 Hologic Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Hologic HIV/AIDS Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Hologic HIV/AIDS Diagnostics Products Offered
      • 11.6.5 Hologic Recent Development
    • 11.7 Alere
      • 11.7.1 Alere Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Alere HIV/AIDS Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Alere HIV/AIDS Diagnostics Products Offered
      • 11.7.5 Alere Recent Development
    • 11.8 Chembio Diagnostic Systems
      • 11.8.1 Chembio Diagnostic Systems Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Chembio Diagnostic Systems HIV/AIDS Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Chembio Diagnostic Systems HIV/AIDS Diagnostics Products Offered
      • 11.8.5 Chembio Diagnostic Systems Recent Development
    • 11.9 Becton, Dickinson and Company
      • 11.9.1 Becton, Dickinson and Company Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Becton, Dickinson and Company HIV/AIDS Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Becton, Dickinson and Company HIV/AIDS Diagnostics Products Offered
      • 11.9.5 Becton, Dickinson and Company Recent Development
    • 11.10 Danaher Corporation (Cepheid)
      • 11.10.1 Danaher Corporation (Cepheid) Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Danaher Corporation (Cepheid) HIV/AIDS Diagnostics Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Danaher Corporation (Cepheid) HIV/AIDS Diagnostics Products Offered
      • 11.10.5 Danaher Corporation (Cepheid) Recent Development

    12 Future Forecast

    • 12.1 HIV/AIDS Diagnostics Market Forecast by Regions
      • 12.1.1 Global HIV/AIDS Diagnostics Sales Forecast by Regions 2019-2025
      • 12.1.2 Global HIV/AIDS Diagnostics Revenue Forecast by Regions 2019-2025
    • 12.2 HIV/AIDS Diagnostics Market Forecast by Product
      • 12.2.1 Global HIV/AIDS Diagnostics Sales Forecast by Product 2019-2025
      • 12.2.2 Global HIV/AIDS Diagnostics Revenue Forecast by Product 2019-2025
    • 12.3 HIV/AIDS Diagnostics Market Forecast by End User
    • 12.4 North America HIV/AIDS Diagnostics Forecast
    • 12.5 Europe HIV/AIDS Diagnostics Forecast
    • 12.6 Asia Pacific HIV/AIDS Diagnostics Forecast
    • 12.7 Central & South America HIV/AIDS Diagnostics Forecast
    • 12.8 Middle East and Africa HIV/AIDS Diagnostics Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 HIV/AIDS Diagnostics Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global HIV/AIDS Diagnostics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the HIV/AIDS Diagnostics market based on company, product type, end user and key regions.

      This report studies the global market size of HIV/AIDS Diagnostics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of HIV/AIDS Diagnostics in these regions.
      This research report categorizes the global HIV/AIDS Diagnostics market by top players/brands, region, type and end user. This report also studies the global HIV/AIDS Diagnostics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Siemens Healthineers
      Bio-Rad
      Abbott Laboratories
      OraSure Technologies
      F. Hoffmann-La Roche
      Hologic
      Alere
      Chembio Diagnostic Systems
      Becton, Dickinson and Company
      Danaher Corporation (Cepheid)

      Market size by Product
      By Product Type
      Kits and Reagents
      Instruments
      Others
      By Test Type
      Rapid Tests (POC)
      ELISA
      Nucleic Acid Tests
      Others
      Market size by End User
      Hospitals
      Private Diagnostic Laboratories
      Academic and Research Institutes
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global HIV/AIDS Diagnostics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of HIV/AIDS Diagnostics market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global HIV/AIDS Diagnostics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of HIV/AIDS Diagnostics submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of HIV/AIDS Diagnostics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of HIV/AIDS Diagnostics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now